Expand PRME Menu
PRME MENU

Prime Medicine (PRME) closed at $3.84 on November 19, 2026, up 0.5% from the previous close, on volume of 3,816,933 shares (30-day average 5,477,486).

Key numbers
  • Last close: $3.84 (November 19, 2026)
  • 52-week range: $2.67 to $5.91
  • Market value: $856.3 million
  • 30-day implied volatility (IV30): 95.2%
  • Option volume: 771 contracts (334 calls, 437 puts); 30-day average 2,723

Data as of November 19, 2026.

PRME Stock Summary and Trading Ideas (Prime Medicine | NASDAQ:PRME)

Charts for Today's Stock Price and Implied Volatility in Prime Medicine

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for PRME by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Nov 12, 2026 Call Spread 21-Jan-282 : 5 C 1,704
2-3 The next 2 largest trades are for Premium members. Start a 7-day free trial

Premium Feature

Login|Subscribe

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 19, 2026. See the largest for 5, 30, 60 and 90 days

Trading Statistics

Key Ratios

Prime Medicine (PRME) Frequently Asked Questions

What does Prime Medicine do?

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

What symbol and exchange does Prime Medicine shares trade?

Prime Medicine trades on the NASDAQ stock market under the symbol PRME.

What is Prime Medicine stock price doing today?

As of November 20, 2026, PRME stock price declined to $3.57 with 3,755,812 million shares trading.

What is Prime Medicine's Beta?

PRME has a beta of 1.65, meaning it tends to be more sensitive to market movements. PRME has a correlation of 0.06 to the broad based SPY ETF.

How much is Prime Medicine worth?

PRME has a market cap of $796.08 million. This is considered a Small Cap stock.

How much money does Prime Medicine make?

Last quarter Prime Medicine reported $4 million in Revenue and -$.22 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.02.

What is the highest and lowest price Prime Medicine traded in the last 3 year period?

In the last 3 years, PRME traded as high as $9.86 and as low as $1.11.

What are the top ETFs holding Prime Medicine?

The top ETF exchange traded funds that PRME belongs to (by Net Assets): ARKG, XBI, VTI, IWM, VXF.

Is Prime Medicine (PRME) a good investment?

PRME has underperformed the market in the last year with a price return of -4.0% while the SPY ETF gained +5.4%. However, in the short term, PRME had mixed performance relative to the market. It has outperformed in the last 3 months, returning +0.8% vs -9.9% return in SPY. But in the last 2 weeks, PRME shares have been beat by the market, returning -19.8% compared to an SPY return of -5.7%.

What are the support and resistance levels for Prime Medicine (PRME)?

PRME support price is $3.55 and resistance is $4.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRME shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes